From $10 to $23? Why Niagen Bioscience (NAGE) Could Be the Next Big Biotech Success Story
Niagen Bioscience Inc. (NASDAQ:NAGE) is a pioneering life sciences company that has become a global leader in the…
Wall Street Is Going Crazy Over UroGen Pharma (URGN) – Here’s Why it Could Be a 2025 Winner
UroGen Pharma Ltd. is a biotechnology company focused on developing and commercializing innovative therapies for urothelial and specialty…
Cel-Sci (CVM) Could Skyrocket 3,000% – Here’s Why Investors Are Buzzing
Cel-Sci Corporation (NYSE:CVM) is gaining renewed attention from both retail and institutional investors as it continues to push…
FDA Decision Incoming! Apellis Pharmaceuticals (APLS) Could Be the Next 10X Biotech Stock!
Apellis Pharmaceuticals Inc (NASDAQ:APLS) is a pioneering biotechnology company dedicated to transforming the treatment landscape for patients living…
From NeuroBo to MetaVia (MTVA): This Biotech Just Went All-In on Obesity and Liver Disease
MetaVia Inc. (NASDAQ:MTVA), formerly NeuroBo Pharmaceuticals, Inc, is a clinical-stage biotechnology company focused on developing next-generation therapies for…
Alterity Therapeutics (ATHE) is One FDA Meeting Away From a Major Breakout
Alterity Therapeutics Ltd. (NASDAQ:ATHE) is a clinical-stage biotechnology company headquartered in Melbourne, Australia, focused on developing innovative therapies…
Liminatus Pharma (LIMN) Might Be the Most Disruptive Micro-Cap on NASDAQ
Liminatus Pharma Inc. (NASDAQ:LIMN) is a preclinical-stage biopharmaceutical company dedicated to the discovery and development of targeted cancer…
Thermo Fisher (TMO) Is Everywhere—And That’s Exactly Why It’s Winning
Thermo Fisher Scientific Inc (NYSE:TMO) is a global leader in the scientific and healthcare solutions industry, renowned for…
Krystal Biotech (KRYS) Just Changed Gene Therapy Forever—Smart Investors Are Paying Attention
Krystal Biotech, Inc. (NASDAQ: KRYS) is a cutting-edge biotechnology company pioneering the development of redosable genetic medicines aimed…
Seres Therapeutics (MCRB): The $100M Microbiome Gem Flying Under Wall Street’s Radar
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneering biotechnology company at the forefront of developing microbiome therapeutics—a groundbreaking class…
Telesurgery Is Here—and Intuitive Surgical (ISRG) Owns It
Intuitive Surgical, Inc., founded in 1995 and headquartered in Sunnyvale, California, is a trailblazer in the field of…
Medpace (MEDP) Just Soared 50%—Is This the Most Underrated Biotech Play of 2025?
Medpace Holdings Inc. (NASDAQ:MEDP) is a leading global contract research organization (CRO) that partners with biopharmaceutical, biotechnology, and…
TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention
TransMedics Group, Inc. (NASDAQ:TMDX) is a pioneering medical technology company that is fundamentally transforming the landscape of organ…
Astera Labs (ALAB) is Down from Highs — But Here’s Why It’s About to Rebound Hard
Astera Labs Inc. (NASDAQ:ALAB) is a rapidly emerging leader in intelligent connectivity solutions designed to address the unique…
Wall Street Sees 75% Upside: Is Replimune (REPL) the Best Biotech Stock to Buy Now?
Replimune Group, Inc. (NASDAQ:REPL) is a biotechnology company pioneering a transformative class of cancer therapeutics based on its…
Smart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones
GlucoTrack Inc. (NASDAQ:GCTK) is a medical technology company revolutionizing diabetes management through the development of its innovative continuous…
Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
Pasithea Therapeutics Corp. (NASDAQ:KTTA) is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for central…
CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play
CNS Pharmaceuticals Inc. (NASDAQ:CNSP) is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel treatments…